Samisubbu Naidu

Indiana University School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Year:

2026

BACKGROUND: The ubiquitin-proteasome system regulates protein degradation and the development of pulmonary arterial hypertension (PAH), but knowledge about the role of deubiquitinating enzymes in this process is limited. UCHL1 (ubiquitin carboxyl-terminal hydrolase 1), a deubiquitinase, has been shown to reduce AKT1 (AKT serine/threonine kinase 1) degradation, resulting in higher levels. Given that AKT1 is pathological in pulmonary hypertension, we hypothesized that UCHL1 deficiency attenuates PAH development by means of reductions in AKT1. METHODS: Tissues from animal pulmonary hypertension models as well as human pulmonary artery endothelial cells from patients with PAH exhibited increased vascular UCHL1 staining and protein expression. Exposure to LDN57444, a UCHL1-specific inhibitor, reduced human pulmonary artery endothelial cell and smooth muscle cell proliferation. Across 3 preclinical PAH models, LDN57444-exposed animals, Uchl1 knockout rats ( Uchl1 −/− ), and conditional Uchl1 knockout mice ( Tie2Cre-Uchl1 fl/fl ) demonstrated reduced right ventricular hypertrophy, right ventricular systolic pressures, and obliterative vascular remodeling. Lungs and pulmonary artery endothelial cells isolated from Uchl1 −/− animals exhibited reduced total and activated Akt with increased ubiquitinated Akt levels. UCHL1-silenced human pulmonary artery endothelial cells displayed reduced lysine(K)63-linked and increased K48-linked AKT1 levels. RESULTS: Supporting experimental data, we found that rs9321, a variant in a GC-enriched region of the UCHL1 gene, is associated with reduced methylation (n=5133), increased UCHL1 gene expression in lungs (n=815), and reduced cardiac index in patients (n=796). In addition, Gadd45α (an established demethylating gene) knockout mice ( Gadd45α −/− ) exhibited reduced lung vascular UCHL1 and AKT1 expression along with attenuated hypoxic pulmonary hypertension. CONCLUSIONS: Our findings suggest that UCHL1 deficiency results in PAH attenuation by means of reduced AKT1, highlighting a novel therapeutic pathway in PAH.

Year:

2024

Year:

2022

Collaborators (14)

Jason X.-J. Yuan

Professor

University of California

UNITED STATES
View details

Daniel Flaherty

Associate Professor

Purdue University

UNITED STATES
View details

Il-man Kim

Associate Professor

Indiana University School of Medicine

UNITED STATES
View details

Yen Chun Charly Lai

Assitant Professor of Medicine

Indiana University

UNITED STATES
View details

Jeffrey R. Jacobson

University of Chicago

UNITED STATES
View details

Joe G.N. Garcia

University of Florida

UNITED STATES
View details

Ankit Desai

Associate Professor

Indiana University School of Medicine

UNITED STATES
View details

Michael Pauciulo

Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES
View details

Jason H. Karnes

-

UNITED STATES
View details

William Nichols

Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES
View details

Noel Warfel

Associate Professor

Medical University of South Carolina

UNITED STATES
View details

James West

Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Julio Duarte

Ohio State University

UNITED STATES
View details

sebastien bonnet

Institut universitaire de cardiologie et de pneumologie de Québec

CANADA
View details